The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension

标题
The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension
作者
关键词
-
出版物
出版商
Elsevier BV
发表日期
2020-01-22
DOI
10.1016/j.bbrc.2020.01.015

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started